Edesa Biotech, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 687.50 K | $1.68 M | 100.00% | 12.96% |
RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 687.50 K | $1.68 M | 100.00% | 12.96% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 687.50 K | $1.68 M | 100.00% | 12.96% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 625.00 K | $1.53 M | 100.00% | 11.78% |
COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 50.00 K | $122.00 K | 100.00% | 0.94% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 28.97 K | $70.70 K | 46.28% | 0.55% |
CIBC WORLD MARKET INC. | 05/14/2025 | 20.00 K | $48.80 K | 100.00% | 0.38% |
CITADEL ADVISORS LLC | 05/15/2025 | 16.59 K | $40.48 K | -59.48% | 0.31% |
VANGUARD GROUP INC | 05/09/2025 | 15.86 K | $38.71 K | 0.00% | 0.30% |
ROYAL BANK OF CANADA | 05/15/2025 | 1.82 K | $4.00 K | 0.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.19 K | $2.91 K | -65.33% | 0.02% |
TD WATERHOUSE CANADA INC. | 05/09/2025 | 142 | $329 | 0.00% | 0.00% |
FIFTH THIRD BANCORP | 04/15/2025 | 100 | $244 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 22 | $54 | 15.79% | 0.00% |
UBS GROUP AG | 05/13/2025 | 4 | $10 | -87.10% | 0.00% |
CREDIT AGRICOLE S A | 05/14/2025 | 1 | $2 | 0.00% | 0.00% |
ALLSQUARE WEALTH MANAGEMENT LLC | 05/06/2025 | 1 | $2 | 0.00% | 0.00% |
04/30/2025 | 1 | $2 | 0.00% | 0.00% | |
MORGAN STANLEY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
CM MANAGEMENT, LLC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
Edesa Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Edesa Biotech, Inc.. The most heavily invested institutionals were:
Stonepine Capital Management, LLC: 687,500
Velan Capital Investment Management LP: 687,500
Rubric Capital Management LP: 687,500
Nantahala Capital Management, LLC: 625,000
COMMONWEALTH EQUITY SERVICES, LLC: 50,003
GEODE CAPITAL MANAGEMENT, LLC: 28,970
53.19% of Edesa Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.82 M shares in the last 24 months. This purchase volume represents approximately $5.42 M in transactions.